These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3361537)

  • 41. The diagnosis and classification of scleroderma (systemic sclerosis).
    Barnett AJ; Miller M; Littlejohn GO
    Postgrad Med J; 1988 Feb; 64(748):121-5. PubMed ID: 3050937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitopoisomerase antibody positivity predates nailfold capillaroscopy abnormalities in scleroderma. Postulated classification of 'prescleroderma'.
    Englert H; Champion D; Wu JC; Giallussi J; McGrath M; Manolios N
    Intern Med J; 2011 Feb; 41(2):197-9. PubMed ID: 22747554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage infiltration in the skin of patients with systemic sclerosis.
    Ishikawa O; Ishikawa H
    J Rheumatol; 1992 Aug; 19(8):1202-6. PubMed ID: 1404154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine.
    Fleischmajer R; Perlish JS; Shaw KV; Pirozzi DJ
    Arch Dermatol; 1976 Nov; 112(11):1553-7. PubMed ID: 984860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.
    Cottrell TR; Wise RA; Wigley FM; Boin F
    Ann Rheum Dis; 2014 Jun; 73(6):1060-6. PubMed ID: 23606705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial progressive systemic scleroderma.
    Greger RE; Greger RE
    Arch Dermatol; 1975 Jan; 111(1):81-5. PubMed ID: 1119827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 48. Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis.
    Clements PJ; Lachenbruch PA; Ng SC; Simmons M; Sterz M; Furst DE
    Arthritis Rheum; 1990 Aug; 33(8):1256-63. PubMed ID: 2390128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical variants of early stages of systemic scleroderma].
    Ievleva LV; Guseva NG; Akimova TF; Mazneva LM
    Ter Arkh; 1975; 47(11):117-21. PubMed ID: 1224294
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations.
    Vayssairat M; Baudot N; Abuaf N; Johanet C
    Clin Rheumatol; 1992 Sep; 11(3):356-63. PubMed ID: 1458783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival.
    Scussel-Lonzetti L; Joyal F; Raynauld JP; Roussin A; Rich E; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2002 Mar; 81(2):154-67. PubMed ID: 11889414
    [No Abstract]   [Full Text] [Related]  

  • 52. Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases.
    Barnett AJ
    Med J Aust; 1978 Aug; 2(4):129-34. PubMed ID: 569246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nailfold capillary abnormalities and organ involvement in scleroderma.
    Houtman NM; Kallenberg CG; Wouda AA
    Arthritis Rheum; 1986 Mar; 29(3):451-2. PubMed ID: 3964324
    [No Abstract]   [Full Text] [Related]  

  • 54. Improvement in skin thickening in systemic sclerosis associated with improved survival.
    Steen VD; Medsger TA
    Arthritis Rheum; 2001 Dec; 44(12):2828-35. PubMed ID: 11762943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital gangrene and anticentromere antibodies without scleroderma.
    Picillo U; Marcialis MR; Matarazzo A; Italiano G; Petti A
    Br J Rheumatol; 1998 Dec; 37(12):1352-3. PubMed ID: 9973164
    [No Abstract]   [Full Text] [Related]  

  • 56. [Progressive systemic scleroderma. Clinical spectrum and prognostic parameters in 131 patients].
    Luderschmidt C; Kaulertz I; König G; Leisner B
    Dtsch Med Wochenschr; 1984 Sep; 109(37):1389-97. PubMed ID: 6479031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluating the cutaneous involvement in scleroderma: torsional stiffness revisited.
    Knight LR; Smeathers JE; Isdale AH; Helliwell PS
    Rheumatology (Oxford); 2001 Feb; 40(2):128-32. PubMed ID: 11257147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sclerodactyly, CREST syndrome, proximal scleroderma.
    Giordano M
    Ann Rheum Dis; 1986 Jan; 45(1):86. PubMed ID: 3954464
    [No Abstract]   [Full Text] [Related]  

  • 59. The pathophysiology of scleroderma.
    Fleischmajer R
    Int J Dermatol; 1977 Jun; 16(5):310-8. PubMed ID: 326693
    [No Abstract]   [Full Text] [Related]  

  • 60. Scleroderma: pathogenic factors and current management.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.